New Cerebral Microbleeds After Catheter‐Based Structural Heart Interventions: An Exploratory Analysis

Author:

Braemswig Tim Bastian1234ORCID,Kusserow Madeleine56,Bellmann Barbara78ORCID,Beckhoff Frederik8ORCID,Reinthaler Markus8910,von Rennenberg Regina1311ORCID,Erdur Hebun13ORCID,Scheitz Jan F.1234ORCID,Galinovic Ivana3ORCID,Villringer Kersten3ORCID,Leistner David M.2481213ORCID,Audebert Heinrich J.13ORCID,Endres Matthias1341114ORCID,Landmesser Ulf24810ORCID,Haeusler Karl Georg15ORCID,Fiebach Jochen B.3ORCID,Lauten Alexander816,Rillig Andreas817ORCID,Nolte Christian H.123411ORCID

Affiliation:

1. Klinik und Hochschulambulanz für Neurologie Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany

2. Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin Berlin Germany

3. Center for Stroke Research Berlin (CSB) Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany

4. German Centre for Cardiovascular Research (DZHK), partner site Berlin Berlin Germany

5. Klinik für Innere Medizin Bundeswehrkrankenhaus Berlin Berlin Germany

6. Charité – Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany

7. MEDIAN Klinik AGZ Düsseldorf Düsseldorf Germany

8. Department of Cardiology Campus Benjamin Franklin Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany

9. Institute of Active Polymers and Berlin‐Brandenburg Center for Regenerative Therapies Helmholtz‐Zentrum Hereon Teltow Germany

10. Deutsches Herzzentrum der Charité, Klinik für Kardiologie Angiologie und Intensivmedizin Berlin Germany

11. German Center for Neurodegenerative Diseases (DZNE), partner site Berlin Berlin Germany

12. Department of Medicine III, Cardiology Goethe University Frankfurt am Main Germany

13. German Centre for Cardiovascular Research (DZHK), partner site Rhine‐Main Frankfurt Germany

14. ExcellenceCluster NeuroCure Berlin Germany

15. Department of Neurology Universitätsklinikum Würzburg Würzburg Germany

16. Department of General and Interventional Cardiology Helios Klinikum Erfurt Erfurt Germany

17. Universitäres Herz‐ und Gefässzentrum Hamburg‐Eppendorf Hamburg Germany

Abstract

Background Cerebral microbleeds (CMBs) are increasingly recognized as “covert” brain lesions indicating increased risk of future neurological events. However, data on CMBs in patients undergoing catheter‐based structural heart interventions are scarce. Therefore, we assessed occurrence and predictors of new CMBs in patients undergoing catheter‐based left atrial appendage closure and percutaneous mitral valve repair using the MitraClip System. Methods and Results We conducted an exploratory analysis using data derived from 2 prospective, observational studies. Eligible patients underwent cerebral magnetic resonance imaging (3 Tesla) examinations and cognitive tests (using the Montreal Cognitive Assessment) before and after catheter‐based left atrial appendage closure and percutaneous mitral valve repair. Forty‐seven patients (53% men; median age, 77 years) were included. New CMBs occurred in 17 of 47 patients (36%) following catheter‐based structural heart interventions. Occurrences of new CMBs did not differ significantly between patients undergoing catheter‐based left atrial appendage closure and percutaneous mitral valve repair (7/25 versus 10/22; P =0.348). In univariable analysis, longer procedure time was significantly associated with new CMBs. Adjustment for heparin attenuated this association (adjusted odds ratio [per 30 minutes]: 1.77 [95% CI, 0.92–3.83]; P =0.090). Conclusions New CMBs occur in approximately one‐third of patients after catheter‐based left atrial appendage closure and percutaneous mitral valve repair using the MitraClip System. Our data suggest that longer duration of the procedure may be a risk factor for new CMBs. Future studies in larger populations are needed to further investigate their clinical relevance. Clinical Trial Registration German Clinical Trials Register: DRKS00010300 ( https://drks.de/search/en/trial/DRKS00010300 ); ClinicalTrials.gov : NCT03104556 ( https://clinicaltrials.gov/ct2/show/NCT03104556?term=NCT03104556&draw=2&rank=1 ).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3